Published : Oct-2017
No. of Pages : 507
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 22
2 Introduction 23
2.1 Prostate Cancer Diagnostic Tests Overview 23
3 Products under Development 24
3.1 Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development 24
3.2 Prostate Cancer Diagnostic Tests - Pipeline Products by Territory 25
3.3 Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 26
3.4 Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 27
3.5 Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials 28
4 Prostate Cancer Diagnostic Tests - Pipeline Products under Development by Companies 29
4.1 Prostate Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 29
4.2 Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development 36
5 Prostate Cancer Diagnostic Tests Companies and Product Overview 42
5.1 3D Biomatrix LLC Company Overview 42
5.2 A&G Pharmaceutical Inc Company Overview 43
5.3 Abnova Corp Company Overview 44
5.4 AccuTech LLC Company Overview 45
5.5 Acobiom Company Overview 46
5.6 Adaptive Biotechnologies Corp Company Overview 47
5.7 Advanced Marker Discovery SL Company Overview 48
5.8 Affinimark Technologies, Inc. Company Overview 52
5.9 AIT Austrian Institute of Technology GmbH Company Overview 53
5.10 Albert Ludwigs University of Freiburg Company Overview 54
5.11 Alere Inc Company Overview 55
5.12 Almac Diagnostics Ltd Company Overview 56
5.13 AltheaDx Inc Company Overview 57
5.14 Ambrilia Biopharma Inc Company Overview 58
5.15 Andro Diagnostics (Inactive) Company Overview 59
5.16 ANGLE plc Company Overview 60
5.17 Armune BioScience Inc Company Overview 61
5.18 Arno Therapeutics Inc Company Overview 62
5.19 Arquer Diagnostics Ltd Company Overview 63
5.20 Arrayit Diagnostics, Inc. Company Overview 66
5.21 Atturos Company Overview 67
5.22 Aurelium BioPharma Inc. Company Overview 68
5.23 Bayer HealthCare AG (Inactive) Company Overview 69
5.24 Baylor College of Medicine Company Overview 71
5.25 Beckman Coulter Inc Company Overview 72
5.26 BioAffinity Technologies, Inc. Company Overview 73
5.27 Biocare Medical LLC Company Overview 74
5.28 Biocrates Life Sciences AG Company Overview 75
5.29 BioMark Diagnostics Inc. Company Overview 76
5.30 bioMerieux S.A. Company Overview 77
5.31 Bioprognos SL Company Overview 79
5.32 Biosceptre International Ltd Company Overview 80
5.33 Biotron Ltd Company Overview 81
5.34 Blondin Bioscience, LLC Company Overview 82
5.35 Caldera Health Limited Company Overview 83
5.36 Cancer Research Technology Ltd Company Overview 84
5.37 Caris Life Sciences Inc Company Overview 85
5.38 Cellanyx Diagnostics, Inc. Company Overview 86
5.39 CellMax Life Company Overview 89
5.40 Cellmid Ltd Company Overview 90
5.41 Cepheid Company Overview 91
5.42 Ceres Nanosciences Inc Company Overview 93
5.43 ChemImage Corp Company Overview 94
5.44 Children's Hospital Boston Company Overview 95
5.45 China Sky One Medical Inc Company Overview 96
5.46 Chronix Biomedical Inc Company Overview 97
5.47 Cleveland Diagnostics Inc. Company Overview 98
5.48 CompanDX Ltd. Company Overview 101
5.49 Cornell University Company Overview 102
5.50 Courtagen Life Sciences Inc Company Overview 103
5.51 CS-Keys, Inc. (Inactive) Company Overview 104
5.52 Cytosystems Ltd Company Overview 105
5.53 Dartmouth College Company Overview 106
5.54 Detroit R&D, Inc. Company Overview 107
5.55 DiagnoCure Inc. (Inactive) Company Overview 108
5.56 Diaxonhit SA Company Overview 109
5.57 Emory University Company Overview 110
5.58 Epic Sciences Inc Company Overview 111
5.59 Epigenomics AG Company Overview 114
5.60 Euclid Diagnostics LLC Company Overview 116
5.61 Eventus Diagnostics Inc (Inactive) Company Overview 117
5.62 Exiqon A/S Company Overview 118
5.63 Exosomics Siena SpA Company Overview 121
5.64 Fluxion Biosciences Inc Company Overview 122
5.65 Fred Hutchinson Cancer Research Center Company Overview 123
5.66 French National Institute of Health and Medical Research Company Overview 124
5.67 Genomic Health Inc Company Overview 125
5.68 Georgia Institute of Technology Company Overview 127
5.69 GILUPI Nanomedizin Company Overview 128
5.70 GlycoZym Company Overview 129
5.71 Gregor Diagnostics Inc Company Overview 130
5.72 Guangdong Medical College Company Overview 131
5.73 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 132
5.74 Hologic Inc Company Overview 135
5.75 Ikonisys Inc Company Overview 137
5.76 Imagion Biosystems Inc Company Overview 138
5.77 Immunovia AB Company Overview 139
5.78 Imperial College London Company Overview 140
5.79 InterGenetics Inc Company Overview 141
5.80 IRIS International Inc Company Overview 142
5.81 IV Diagnostics Inc Company Overview 143
5.82 Janssen Biotech Inc Company Overview 144
5.83 John Hopkins University Company Overview 145
5.84 KineMed Inc Company Overview 149
5.85 King Abdullah University of Science and Technology Company Overview 150
5.86 Luminor Medical Technologies Inc Company Overview 151
5.87 MabCure Inc. Company Overview 152
5.88 MacroArray Technologies LLC Company Overview 153
5.89 Mayo Clinic US Company Overview 156
5.90 MDNA Life Sciences Inc Company Overview 157
5.91 MDxHealth SA Company Overview 159
5.92 Metabolomic Technologies Inc Company Overview 161
5.93 Metanomics Health GmbH Company Overview 162
5.94 MetaStat Inc Company Overview 163
5.95 Micromedic Technologies Ltd Company Overview 164
5.96 Milagen Inc Company Overview 165
5.97 Minomic International Ltd Company Overview 166
5.98 Myriad Genetics Inc Company Overview 169
5.99 Nano Discovery Inc. Company Overview 170
5.100 Nanocytomics LLC Company Overview 171
5.101 NanoIVD Inc Company Overview 172
5.102 Nanostics Inc Company Overview 173
5.103 NeuroBioTex Inc Company Overview 174
5.104 Northwestern University Company Overview 175
5.105 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 176
5.106 Nuclea Biotechnologies Inc. (Inactive) Company Overview 177
5.107 Numares AG Company Overview 179
5.108 NuView Life Sciences Inc Company Overview 180
5.109 Olympia Diagnostics, Inc Company Overview 183
5.110 Onconome, Inc. (Inactive) Company Overview 187
5.111 ONCOVEDA Cancer Research Center Company Overview 189
5.112 OncoVista Innovative Therapies Inc Company Overview 190
5.113 On-Q-ity, Inc. (Inactive) Company Overview 191
5.114 Ontario Institute for Cancer Research Company Overview 192
5.115 Orion Genomics LLC Company Overview 193
5.116 Ortho-Clinical Diagnostics Inc Company Overview 194
5.117 Oryzon Genomics SA Company Overview 195
5.118 OTraces Inc. Company Overview 197
5.119 Panacea Pharmaceuticals Inc Company Overview 198
5.120 PharmaSeq Inc Company Overview 199
5.121 Precision Biologics Inc Company Overview 200
5.122 Predictive Biosciences Inc Company Overview 201
5.123 PrognosDx Health Inc Company Overview 203
5.124 Prostate Management Diagnostics Inc Company Overview 204
5.125 Protagen AG Company Overview 206
5.126 Proteocyte Diagnostics Inc Company Overview 207
5.127 ProteoMediX AG Company Overview 208
5.128 Proteomika Company Overview 211
5.129 Proveri Inc. (Inactive) Company Overview 212
5.130 Qiagen NV Company Overview 215
5.131 Quanterix Corp Company Overview 216
5.132 Rappaport Family Institute for Research in the Medical Science Company Overview 218
5.133 RiboMed Biotechnologies Inc Company Overview 219
5.134 Roche Diagnostics International Ltd Company Overview 220
5.135 Roswell Park Cancer Institute Company Overview 221
5.136 Siamab Therapeutics Inc Company Overview 222
5.137 Siemens Healthcare GmbH Company Overview 223
5.138 Sienna Cancer Diagnostics Ltd Company Overview 224
5.139 Sividon Diagnostics GmbH Company Overview 225
5.140 Soricimed Biopharma Inc Company Overview 226
5.141 Source MDx Company Overview 228
5.142 Stage I Diagnostics Inc Company Overview 230
5.143 Target Discovery Inc (Inactive) Company Overview 231
5.144 The University of South Australia Company Overview 232
5.145 Thermo Fisher Scientific Inc Company Overview 233
5.146 TRACON Pharmaceuticals Inc Company Overview 234
5.147 Tyrian Diagnostics Ltd Company Overview 235
5.148 University College Dublin Company Overview 236
5.149 University of Arizona Company Overview 237
5.150 University of California Los Angeles Company Overview 238
5.151 University of Central Florida Company Overview 239
5.152 University of Chicago Company Overview 240
5.153 University of Colorado Company Overview 241
5.154 University of Connecticut Company Overview 242
5.155 University of Gottingen Company Overview 243
5.156 University of Iowa Company Overview 244
5.157 University of Malaya Company Overview 245
5.158 University of Maryland Baltimore Company Overview 246
5.159 University of Michigan Company Overview 247
5.160 University of Oslo Company Overview 248
5.161 University of Otago Company Overview 249
5.162 University of South Florida Company Overview 250
5.163 University of Strathclyde Company Overview 251
5.164 University of Washington Company Overview 252
5.165 Uppsala University Company Overview 253
5.166 US Biomarkers Inc Company Overview 254
5.167 Vermillion Inc Company Overview 255
5.168 Vitatex Inc. Company Overview 257
5.169 Vitrimark Inc (Inactive) Company Overview 258
5.170 Vitruvian Biomedical Inc Company Overview 259
5.171 VolitionRX Ltd Company Overview 260
5.172 ZEUS Scientific Inc Company Overview 263
6 Prostate Cancer Diagnostic Tests - Recent Developments 264
6.1 Sep 13, 2017: HIFU for Prostate Cancer now Available at North Carolina Specialty Hospital in Durham, North Carolina 264
6.2 Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion 264
6.3 Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories 265
6.4 Sep 01, 2017: Aeterna Zentaris Announces Departure of Vice President, Finance & Chief Accounting Officer 266
6.5 Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results 266
6.6 Aug 31, 2017: EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU 268
6.7 Aug 31, 2017: Sienna Cancer Diagnostics: Appendix 4E & 2017 Financial Report Release 269
6.8 Aug 30, 2017: bioMerieux - First-Half 2017 Results 269
6.9 Aug 24, 2017: AroCell: Interim report, Q2 2017 272
6.10 Aug 24, 2017: New imaging technique spots prostate tumours starved of oxygen 274
6.11 Aug 22, 2017: Blood Test Predicts Prostate Tumor Resistance 275
6.12 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers 276
6.13 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 277
6.14 Aug 16, 2017: Dr. Jatin P. Shah, International Leader in Head and Neck Surgery, joins Proteocyte Diagnostics' Clinical Advisory Board 277
6.15 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 278
6.16 Aug 14, 2017: Cancer Genetics Announces Second Quarter 2017 Financial Results, Accretive Acquisition and Capital Raise 279
6.17 Aug 10, 2017: ConfirmMDx Study Provides Further Validation of Epigenetic Risk Profile 281
6.18 Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 282
6.19 Aug 10, 2017: Aeterna Zentaris Reports Second Quarter 2017 Financial and Operating Results 284
6.20 Aug 09, 2017: Geron Reports Second Quarter 2017 Financial Results 286
6.21 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update 287
6.22 Aug 08, 2017: MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group 288
6.23 Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results 289
6.24 Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion 290
6.25 Aug 07, 2017: First Human Application of Novel PET Tracer for Prostate Cancer 291
6.26 Aug 03, 2017: Exosome Diagnostics Achieves ISO 13485 Certification 292
6.27 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 292
6.28 Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress 294
6.29 Aug 01, 2017: Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA 296
6.30 Jul 28, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017 296
6.31 Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting 298
6.32 Jul 27, 2017: Ipsen Delivers Strong Sales Growth of 18.8% in the First Half of 2017 and Upgrades Its Guidance for Full Year 2017 298
6.33 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017 307
6.34 Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 311
6.35 Jul 25, 2017: NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017 311
6.36 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 312
6.37 Jul 20, 2017: Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO 314
6.38 Jul 18, 2017: Minomic Launches US Prospective Study of MiCheck Prostate Cancer Test 315
6.39 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 316
6.40 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 318
6.41 Jul 10, 2017: Novus Therapeutics Announces Change in Management 319
6.42 Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017 319
7 Appendix 501
7.1 Methodology 501
7.2 About GlobalData 504
7.3 Contact Us 504
7.4 Disclaimer 504
1.1 List of Tables
Table 1: Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development 27
Table 2: Prostate Cancer Diagnostic Tests - Pipeline Products by Territory 28
Table 3: Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 29
Table 4: Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 30
Table 5: Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials 31
Table 6: Prostate Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 32
Table 7: Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development 39
Table 8: 3D Biomatrix LLC Pipeline Products & Ongoing Clinical Trials Overview 45
Table 9: 3D Cell Assay - Metastatic Prostate Cancer - Product Status 45
Table 10: 3D Cell Assay - Metastatic Prostate Cancer - Product Description 45
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 12: Companion Diagnostic Test - Prostate Cancer - Product Status 46
Table 13: Companion Diagnostic Test - Prostate Cancer - Product Description 46
Table 14: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview 47
Table 15: Biomarker Test - Prostate Cancer - Product Status 47
Table 16: Biomarker Test - Prostate Cancer - Product Description 47
Table 17: AccuTech LLC Pipeline Products & Ongoing Clinical Trials Overview 48
Table 18: PSA Test - Product Status 48
Table 19: PSA Test - Product Description 48
Table 20: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 49
Table 21: Companion Diagnostic Assay - Prostate Cancer - Product Status 49
Table 22: Companion Diagnostic Assay - Prostate Cancer - Product Description 49
Table 23: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 50
Table 24: Ipilimumab Based Companion Diagnostic Test - Product Status 50
Table 25: Ipilimumab Based Companion Diagnostic Test - Product Description 50
Table 26: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 51
Table 27: 2nd Generation Prostate Cancer Test - Product Status 51
Table 28: 2nd Generation Prostate Cancer Test - Product Description 51
Table 29: 3rd Generation Prostate Cancer Test - Product Status 52
Table 30: 3rd Generation Prostate Cancer Test - Product Description 52
Table 31: 4th Generation Prostate Cancer Test - Product Status 52
Table 32: 4th Generation Prostate Cancer Test - Product Description 53
Table 33: Prognostic Test - Prostate Cancer - Product Status 53
Table 34: Prognostic Test - Prostate Cancer - Product Description 53
Table 35: Urine Based Diagnostic Test - Prostate Cancer - Product Status 54
Table 36: Urine Based Diagnostic Test - Prostate Cancer - Product Description 54
Table 37: Affinimark Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 38: Prostalent Diagnostic Test - Product Status 55
Table 39: Prostalent Diagnostic Test - Product Description 55
Table 40: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
Table 41: Biomarker Assay - Prostate Cancer - Product Status 56
Table 42: Biomarker Assay - Prostate Cancer - Product Description 56
Table 43: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 57
Table 44: Urine Based Non-Invasive Prostate Cancer Assay - Product Status 57
Table 45: Urine Based Non-Invasive Prostate Cancer Assay - Product Description 57
Table 46: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 47: NMP48 Test - Product Status 58
Table 48: NMP48 Test - Product Description 58
Table 49: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
Table 50: Prostate Cancer Metastatic Assay - Product Status 59
Table 51: Prostate Cancer Metastatic Assay - Product Description 59
Table 52: AltheaDx Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 53: Prognostic Assay - Prostate Cancer - Product Status 60
Table 54: Prognostic Assay - Prostate Cancer - Product Description 60
Table 55: Ambrilia Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 56: PSP94 Immunoassay - Product Status 61
Table 57: PSP94 Immunoassay - Product Description 61
Table 58: Andro Diagnostics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62
Table 59: Diagnostic Test - Prostate Cancer - Product Status 62
Table 60: Diagnostic Test - Prostate Cancer - Product Description 62
Table 61: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 62: Parsortix-Based Test - Prostate Cancer - Product Status 63
Table 63: Parsortix-Based Test - Prostate Cancer - Product Description 63
Table 64: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 65: Diagnostic Test - Prostate Cancer - Product Status 64
Table 66: Diagnostic Test - Prostate Cancer - Product Description 64
Table 67: Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 68: Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Status 65
Table 69: Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Description 65
Table 70: Arquer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 66
Table 71: UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Product Status 66
Table 72: UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Product Description 66
Table 73: Arquer Diagnostics Ltd - Ongoing Clinical Trials Overview 67
Table 74: UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Study of Arquer's Mcm5-ELISA Test for Prostate Cancer 68
Table 75: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
Table 76: Microarray-Based Diagnostic Test - Prostate Cancer - Product Status 69
Table 77: Microarray-Based Diagnostic Test - Prostate Cancer - Product Description 69
Table 78: Atturos Pipeline Products & Ongoing Clinical Trials Overview 70
Table 79: OCProDx - Product Status 70
Table 80: OCProDx - Product Description 70
Table 81: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 82: Prostate Cancer Screening Test - Product Status 71
Table 83: Prostate Cancer Screening Test - Product Description 71
Table 84: Bayer HealthCare AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 72
Table 85: ODM-201 Based Companion Diagnostic Assay - Product Status 72
Table 86: ODM-201 Based Companion Diagnostic Assay - Product Description 72
Table 87: PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Status 73
Table 88: PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Description 73
Table 89: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 74
Table 90: Diagnostic Assay - Prostate Cancer - Product Status 74
Table 91: Diagnostic Assay - Prostate Cancer - Product Description 74
Table 92: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 75
Table 93: UniCel DxC 600i Synchron Access BPH-A Assay - Product Status 75
Table 94: UniCel DxC 600i Synchron Access BPH-A Assay - Product Description 75
Table 95: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
Table 96: CyPath Diagnostic Assay - Prostate Cancer - Product Status 76
Table 97: CyPath Diagnostic Assay - Prostate Cancer - Product Description 76
Table 98: Biocare Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 77
Table 99: Clear View - Prostate Cancer - Product Status 77
Table 100: Clear View - Prostate Cancer - Product Description 77
Table 101: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview 78
Table 102: Metabolomic Biomarker Assay - Prostate Cancer - Product Status 78
Table 103: Metabolomic Biomarker Assay - Prostate Cancer - Product Description 78
Table 104: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
Table 105: Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Status 79
Table 106: Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Description 79
Table 107: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 80
Table 108: Annexin A3 Prostate Cancer Marker - Product Status 80
Table 109: Annexin A3 Prostate Cancer Marker - Product Description 80
Table 110: Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status 81
Table 111: Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description 81
Table 112: Diagnostic Assay - Prostate Cancer - Product Status 81
Table 113: Diagnostic Assay - Prostate Cancer - Product Description 81
Table 114: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview 82
Table 115: MBDAA Prostate Cancer Test - Product Status 82
Table 116: MBDAA Prostate Cancer Test - Product Description 82
Table 117: Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview 83
Table 118: Prostate Cancer IHC Diagnostic Test - Product Status 83
Table 119: Prostate Cancer IHC Diagnostic Test - Product Description 83
Table 120: Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview 84
Table 121: C-Test - Prostrate Cancer - Product Status 84
Table 122: C-Test - Prostrate Cancer - Product Description 84
Table 123: Blondin Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 85
Table 124: FACT Assay - Metastatic Prostate Cancer - Product Status 85
Table 125: FACT Assay - Metastatic Prostate Cancer - Product Description 85
Table 126: Caldera Health Limited Pipeline Products & Ongoing Clinical Trials Overview 86
Table 127: ProscaNZ - Product Status 86
Table 128: ProscaNZ - Product Description 86
Table 129: Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
Table 130: IHC Based Test - Prostate Cancer - Product Status 87
Table 131: IHC Based Test - Prostate Cancer - Product Description 87
Table 132: Caris Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Table 133: Diagnostic Test - PSA - Product Status 88
Table 134: Diagnostic Test - PSA - Product Description 88
Table 135: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
Table 136: Cellanyx Test - Prostate Cancer - Product Status 89
Table 137: Cellanyx Test - Prostate Cancer - Product Description 89
Table 138: Cellanyx Diagnostics, Inc. - Ongoing Clinical Trials Overview 90
Table 139: Cellanyx Test - Prostate Cancer - A Novel Live Cell Microfluidic Diagnostic Using Phenotypic Biomarkers with Objective Algorithmic Analysis for Prostate Cancer Risk Stratification 91
Table 140: CellMax Life Pipeline Products & Ongoing Clinical Trials Overview 92
Table 141: Cellmax - Prostate Cancer - Product Status 92
Table 142: Cellmax - Prostate Cancer - Product Description 92
Table 143: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 93
Table 144: MK-ELISA Assay - Prostate Cancer - Product Status 93
Table 145: MK-ELISA Assay - Prostate Cancer - Product Description 93
Table 146: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 94
Table 147: Xpert Prostate CA Early Detection Test - Product Status 94
Table 148: Xpert Prostate CA Early Detection Test - Product Description 94
Table 149: Xpert Prostate Cancer Recurrence Risk Test - Product Status 95
Table 150: Xpert Prostate Cancer Recurrence Risk Test - Product Description 95
Table 151: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 96
Table 152: Nanotrap Prostate Cancer Biomarker Test - Product Status 96
Table 153: Nanotrap Prostate Cancer Biomarker Test - Product Description 96
Table 154: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 97
Table 155: Prognostic Test - Prostate Cancer - Product Status 97
Table 156: Prognostic Test - Prostate Cancer - Product Description 97
Table 157: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 98
Table 158: Collagen XXIII Biomarker Assay - Prostate Cancer - Product Status 98
Table 159: Collagen XXIII Biomarker Assay - Prostate Cancer - Product Description 98
Table 160: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 99
Table 161: Diagnostic Kit - Human Prostate Specific Antigen - Product Status 99
Table 162: Diagnostic Kit - Human Prostate Specific Antigen - Product Description 99
Table 163: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 100
Table 164: Companion Diagnostic Test - Prostate Cancer - Product Status 100
Table 165: Companion Diagnostic Test - Prostate Cancer - Product Description 100
Table 166: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
1.2 List of Figures
Figure 1: Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development 27
Figure 2: Prostate Cancer Diagnostic Tests - Pipeline Products by Territory 28
Figure 3: Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 29
Figure 4: Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 30
Figure 5: Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials 31
